MDG — Medicalgorithmics SA Income Statement
0.000.00%
Last trade - 00:00
- PLN268.72m
- PLN248.92m
- PLN43.10m
- 29
- 17
- 58
- 24
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 174 | 112 | 48.3 | 62.7 | 43.1 |
Cost of Revenue | |||||
Gross Profit | 9.53 | -33.7 | 13.4 | 17 | 2.06 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 174 | 149 | 58 | 45.5 | 42.7 |
Operating Profit | -0.085 | -37.5 | -9.63 | 17.2 | 0.433 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.65 | -40 | -7.01 | 25.3 | -0.238 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.299 | -27.7 | -6.57 | 25.5 | -0.578 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.28 | -12.9 | -181 | -11.9 | -0.578 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.28 | -12.9 | -181 | -11.9 | -0.578 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.21 | -3.27 | 1.67 | 4.33 | -0.05 |
Dividends per Share |